Cargando…
Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validity
BACKGROUND: Population external validity is the extent to which an experimental study results can be generalized from a specific sample to a defined population. In order to apply the results of a study, we should be able to assess its population external validity. We performed an investigator-initia...
Autores principales: | Daitch, Vered, Paul, Mical, Daikos, George L., Durante-Mangoni, Emanuele, Yahav, Dafna, Carmeli, Yehuda, Benattar, Yael Dishon, Skiada, Anna, Andini, Roberto, Eliakim-Raz, Noa, Nutman, Amir, Zusman, Oren, Antoniadou, Anastasia, Cavezza, Giusi, Adler, Amos, Dickstein, Yaakov, Pavleas, Ioannis, Zampino, Rosa, Bitterman, Roni, Zayyad, Hiba, Koppel, Fidi, Zak-Doron, Yael, Levi, Inbar, Babich, Tanya, Turjeman, Adi, Ben-Zvi, Haim, Friberg, Lena E., Mouton, Johan W., Theuretzbacher, Ursula, Leibovici, Leonard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010276/ https://www.ncbi.nlm.nih.gov/pubmed/33789574 http://dx.doi.org/10.1186/s12879-021-05995-y |
Ejemplares similares
-
Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol
por: Dickstein, Yaakov, et al.
Publicado: (2016) -
Optimizing patient recruitment into clinical trials of antimicrobial-resistant pathogens
por: Paul, Mical, et al.
Publicado: (2023) -
Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii
por: Kon, Hadas, et al.
Publicado: (2023) -
Duration of antibiotic treatment for Gram-negative bacteremia – Systematic review and individual participant data (IPD) meta-analysis
por: Turjeman, Adi, et al.
Publicado: (2022) -
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study
por: Turjeman, Adi, et al.
Publicado: (2021)